Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin type A for mandibular condyle position in muscular temporomandibular disorder
RBR-2b23xmRecruiting
- Sponsor
- Centro Universitário Hermínio Ometto
- Start
- Jan 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised trial in temporomandibular disorder (TMD) and bruxism comparing botulinum toxin type A with Placebo: normal saline (2 arms). Primary endpoint: Change in condylar position. Started Jan 2020; status: recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
temporomandibular disorder (TMD)bruxism
Beyond the preview
Go deeper on RBR-2b23xm.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-2b23xm.